Skip To Main Content
Joanna Porter on Muck Rack

Joanna Porter

England, London
As seen in: Thorax, Medscape, The Drum, The Lancet, eLife, European Respiratory Journal, Journal of Nuclear Medicine
Our mission is to raise awareness and inspire fundraising for research into pulmonary fibrosis and lung infection, supporting research at UCL Respiratory
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Joanna

Contact Joanna, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Anti-inflammatory therapy with nebulized dornase alfa for severe COVID-19 pneumonia: a randomized unblinded trial

|
By Joanna Porter, Jamie R.J. Inshaw, Emma Denneny, Rebecca Evans
| eLife
eLife assessment This small-sized clinical trial comparing nebulized dornase-alfa to the best available care in patients hospitalized with COVID-19 pneumonia is valuable, but in its present form the paper is incomplete.
Open in Who Shared Issue with article?

[18F]FDG PET/CT Signal Correlates with Neoangiogenesis Markers in Patients with Fibrotic Interstitial Lung Disease Who Underwent Lung Biopsy: Implication for the Use of PET/CT in Diffuse Lung Diseases

|
By Joanna Porter, Balaji Ganeshan, Thida Win, Francesco Fraioli
| Journal of Nuclear Medicine Verified
MATERIALS AND METHODS This prospective, single-center study was approved by the London-Harrow Research Ethics Committee (reference 06/Q0505/22), and all participants signed an informed consent form. In total, 18 patients were included in the study on the basis of having a radiologic diagnosis of fILD and either having had or being scheduled to have a clinically required biopsy of an area of lung determined radiographically.
Open in Who Shared Issue with article?

Early-phase clinical trials in a pandemic: learning from the response to COVID-19

|
By Alex Horsley, Chris Brightling, Jane Davies, Ratko Djukanovic, Liam Heaney, Tracy Hussell, Stefan J. Marciniak, Lorcan McGarvey, Joanna Porter, Thomas Wilkinson, Ling-Pei Ho
| The Lancet Verified
The first cases of the novel SARS-CoV-2 virus emerged at the end of 2019 in Wuhan, China. Within 2 months, WHO had declared a public health emergency and the first cases were detected in the UK. The rapid spread of SARS-CoV-2 caused widespread disruption across society and health care, and left little time to plan and design research needed in the context of a new pandemic.
Open in Who Shared Issue with article?
See all 14 licensed articles (15 Total)